Articles

Podcasts

Videos

Clinical

Compared to fidaxomicin and vancomycinfecal, microbiota transplant (FMT) was the most cost-effective treatment for first and subsequent recurrent C difficile infection.

FMT Cost-Effective for 90% of Recurrent C Difficile Infections

 Texas judge Reed O’Connor ruled that requiring employers to cover the medical expense of HIV PrEP is a violation of religious freedom. 

Texas Judge Rules Employers Shouldn’t Be Required to Cover HIV PrEP 

The FDA lifted a clinical hold on investigational lenacapavir for HIV treatment and pre-exposure prophylaxis. All clinical studies evaluating injectable lenacapavir can now resume.

FDA Lifts Clinical Hold of Lenacapavir for HIV Treatment and Prevention 

Dr. Simon Portsmouth of Shionogi discusses the trial results of their once-daily oral COVID-19 antiviral, S-217622, as well as the significance of the therapy as vaccine efficacy wanes in the age of Omicron.

Developing a COVID-19 Antiviral for Treatment and Prevention

In Germany, HIV pre-exposure prophylaxis users are recommended to receive regular HIV, STI, and renal function testing. How frequently are PrEP users getting tested? 

PrEP User Adherence to Regular HIV Testing Recommendations

A large surveillance study of 2 symptom-reporting databases found side effects after Moderna or Pfizer-BioNTech COVID-19 vaccination were frequently nonserious and resolved within 1-2 days.

Large Study Confirms mRNA COVID-19 Vaccine Side Effects are Mild and Temporary

“People don’t recognize that at least 1 in 5 of the deaths from opioids may result from endocarditis,” said National Institute of Drug Abuse (NIDA) director Dr. Nora Volkow, adding that endocarditis is “100% preventable.”

Seeking Solutions for Endocarditis in People Who Inject Drugs

Convalescent plasma safely raised antibody levels in children at high risk of severe or fatal COVID-19, successfully neutralizing the virus but unlikely to provide lasting protection.

Convalescent Plasma May Safely Treat Children at High Risk of Severe COVID-19

Two different doses of the company's mRNA vaccine were found to increase antibodies by up to 83-fold.

PREVENTION

Latest News